Search results
Showing 586 to 600 of 1422 results for social care
Ruxolitinib for treating non-segmental vitiligo in people 12 years and over [ID3998]
In development [GID-TA10893] Expected publication date: TBC
This guideline covers risk assessment, prevention and treatment in children, young people and adults at risk of, or who have, a pressure ulcer (also known as a bedsore or pressure sore). It aims to reduce the number of pressure ulcers in people admitted to secondary or tertiary care or receiving NHS care in other settings, such as primary and community care and emergency departments.
Links to our annual reports and business plan
available to all NHS and public health staff, and many other health and social care staff on NHS commissioned work. Your application...
Tools and resources to help you implement guidance and quality standards at work.
Tools and resources to help you implement guidance and quality standards at work.
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)
This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated with diabetes.
conjunction with all MIBs. MIBs are NICE advice, designed to support NHS and social care commissioners and staff when considering using...
Learn from NICE International, part of the UK’s National Institute for Health and Care Excellence, about how to improve your nation’s health and wellbeing
Tools for building or evaluating a medtech evidence base with NICE
Learning disabilities: health checks and action plans (IND265)
This indicator covers the percentage of patients on the learning disability register who received a learning disability health check and had a completed health action plan in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM249
Coeliac disease: recognition, assessment and management (NG20)
This guideline covers the recognition, assessment and management of coeliac disease in children, young people and adults.
In development [GID-TA11288] Expected publication date: 23 April 2025
talented, friendly people on services that have a real impact on health and social care in the UK. Take a look at our current...
Our associates help us to support and promote high quality, safe, cost-effective prescribing and medicines optimisation.